                                                                                                                   
                                                   UNITED STATES                                                   
                                                                                                                   
                                                                                                                   
                                        SECURITIES AND EXCHANGE COMMISSION                                         
                                                                                                                   
                                                                                                                   
                                               Washington, DC 20549                                                
                                                                                                                   
                                                                                                                   
                                                     FORM 8-K                                                      
                                                                                                                   
                                                                                                                   
                                                  CURRENT REPORT                                                   
                                                                                                                   
                                                                                                                   
                                      Pursuant to Section 13 or 15(d) of The                                       
                                                                                                                   
                                                                                                                   
                                          Securities Exchange Act of 1934                                          
                                                                                                                   
                                 Date of report (Date of earliest event reported):                                 
                                                                                                                   
                                                  April 15, 2025                                                   
                                                                                                                   
                                                                                                                   
                                                 Johnson & Johnson                                                 
                                                                                                                   
                              (Exact name of registrant as specified in its charter)                               
                                                                                 
  New Jersey                      1-3215                     22-1024240          
  (State or Other Jurisdiction    -Commission File Number    -IRS Employer       
  of Incorporation)                                          Identification No.  
                                                                                 
                           One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933                            
                                                                                                                   
                                     (Address of Principal Executive Offices)                                      
                                                                                                                   
                                                    (Zip Code)                                                     
                                                                                                                   
                                Registrant's telephone number, including area code:                                
                                                                                                                   
                                                   732- 524-0400                                                   
                                                                                                                   
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation
of the registrant under any of the following provisions:
                                                                                                               
  ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)                   
  ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)                  
  ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  
  ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))  
                                                                                                               
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the
Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2
of this chapter).
                                
  Emerging growth company    ☐  
                                
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section
13(a) of the Exchange Act. ☐
                            SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT                             
                                                                                                    
  Title of each class               Trading Symbol(s)    Name of each exchange on which registered  
  Common Stock, Par Value $1.00     JNJ                  New York Stock Exchange                    
  1.150% Notes Due November 2028    JNJ28                New York Stock Exchange                    
  2.700% Notes due February 2029    JNJ29B               New York Stock Exchange                    
  3.200% Notes Due June 2032        JNJ32                New York Stock Exchange                    
  3.050% Notes due February 2033    JNJ33B               New York Stock Exchange                    
  1.650% Notes Due May 2035         JNJ35                New York Stock Exchange                    
  3.350% Notes Due June 2036        JNJ36A               New York Stock Exchange                    
  3.350% Notes due February 2037    JNJ37B               New York Stock Exchange                    
  3.550% Notes Due June 2044        JNJ44                New York Stock Exchange                    
  3.600% Notes due February 2045    JNJ45                New York Stock Exchange                    
  3.700% Notes due February 2055    JNJ55                New York Stock Exchange                    
                                                                                                    
Item 2.02 Results of operations and financial condition

On April 15, 2025, Johnson & Johnson issued the attached press release (Exhibit 99.1) announcing its sales and
earnings for the first quarter ended March 30, 2025.
                                                                                                                   
  Item 8.01 Other Events                                                                                           
                                                                                                                   
On April 15, 2025, Johnson & Johnson issued the attached press release (Exhibit 99.3) announcing that its Board of
Directors declared a 4.8% increase in the quarterly dividend, from $1.24 per share to $1.30 per share, marking the
63rd year of consecutive increases. At the new rate, the indicated dividend on an annual basis is $5.20 per share
compared to the previous rate of $4.96 per share. The next quarterly dividend is payable on June 10, 2025 to
shareholders of record at the close of business on May 27, 2025. The ex-dividend date is May 27, 2025.
                                                                                                                   
  Item 9.01 Financial statements and exhibits                                                                      
                                                                                                                   
(d) Exhibits.
                                                                                                                   
  Exhibit No.    Description of Exhibit                                                                            
  99.1           Press Release datedApril15, 2025 for the period endedMarch30, 2025                                
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────── 
  99.2           Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings   
                 for the fiscalfirstquarter                                                                        
  99.3           Press Release dated April 15, 2025                                                                
  104            The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.                    
                                                                                                                   
                                                    Signatures                                                     
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.

Date: April 15, 2025
                                         
         JOHNSON & JOHNSON               
         -Registrant                     
  By:    /s/Robert J. Decker, Jr.        
         Robert J. Decker, Jr.           
         Controller                      
         (Principal Accounting Officer)  
                                         
